These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1384957)

  • 1. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
    Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
    Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in keratin expression during the development of benign prostatic hyperplasia.
    Xue Y; Smedts F; Umbas R; Aalders TW; Debruyne FM; de la Rosette JJ; Schalken JA
    Eur Urol; 1997; 32(3):332-8. PubMed ID: 9358223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma.
    Wernert N; Seitz G; Achtstätter T
    Pathol Res Pract; 1987 Oct; 182(5):617-26. PubMed ID: 2446293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of basal cell keratins in human prostate cancer metastases and cell lines.
    van Leenders GJ; Aalders TW; Hulsbergen-van de Kaa CA; Ruiter DJ; Schalken JA
    J Pathol; 2001 Dec; 195(5):563-70. PubMed ID: 11745692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin immunoreactivity in the benign and neoplastic human prostate.
    Brawer MK; Peehl DM; Stamey TA; Bostwick DG
    Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines.
    Nagle RB; Ahmann FR; McDaniel KM; Paquin ML; Clark VA; Celniker A
    Cancer Res; 1987 Jan; 47(1):281-6. PubMed ID: 2431765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue.
    Uzgare AR; Xu Y; Isaacs JT
    J Cell Biochem; 2004 Jan; 91(1):196-205. PubMed ID: 14689591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M; Troncoso P; Bruns C; Bar-Eli M
    Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.
    van Leenders G; van Balken B; Aalders T; Hulsbergen-van de Kaa C; Ruiter D; Schalken J
    Prostate; 2002 May; 51(2):98-107. PubMed ID: 11948964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique features of the basal cells of human prostate epithelium.
    El-Alfy M; Pelletier G; Hermo LS; Labrie F
    Microsc Res Tech; 2000 Dec; 51(5):436-46. PubMed ID: 11074614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU; Haber MM; Chen X
    Prostate; 2007 Nov; 67(15):1686-92. PubMed ID: 17879949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin profiling in the developing human prostate. A different approach to understanding epithelial lineage.
    Trompetter M; Smedts F; van der Wijk J; Schoots C; de Jong HJ; Hopman A; de la Rosette J
    Anticancer Res; 2008; 28(1A):237-43. PubMed ID: 18383851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging of the prostate epithelial stem/progenitor cell.
    Zenzmaier C; Untergasser G; Berger P
    Exp Gerontol; 2008 Nov; 43(11):981-5. PubMed ID: 18639623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
    Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
    Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells.
    Goossens K; Deboel L; Swinnen JV; Roskams T; Manin M; Rombauts W; Verhoeven G
    Prostate; 2002 Sep; 53(1):34-49. PubMed ID: 12210478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives.
    Xue Y; Smedts F; Verhofstad A; Debruyne F; de la Rosette J; Schalken J
    Prostate Suppl; 1998; 8():62-73. PubMed ID: 9690665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.